Updates

Get Alerts
With a free MyAccess profile, you can sign up to receive an email alert when new content is published on this site.
May 28, 2021 | Hurst's the Heart Updates
HOST-EXAM: Aspirin Versus Clopidogrel Chronic Maintenance Monotherapy After PCI
Steven A. Alexander, George Dangas
May 28, 2021 | Hurst's the Heart Updates
GALACTIC-HF: How Does Ejection Fraction Influence the Effect of Omecamtiv Mecarbil on Clinical Patient Outcomes?
Benjamin Bier, Anuradha Lala
May 28, 2021 | Hurst's the Heart Updates
Review of Atlantis Trial
Chi Zhang, Martin Goldman
May 28, 2021 | Hurst's the Heart Updates
VOYAGER-PAD: Rivaroxaban Reduces Total Ischemic Events after Peripheral Arterial Revascularization
Chris Pumill, Daniella Kadian-Dodov
May 28, 2021 | Hurst's the Heart Updates
Ticagrelor versus Clopidogrel in Stabilized Patients with Acute Myocardial Infarction (AMI) – Justifying a Dual-Antiplatelet Therapy (DAPT) De-escalation Protocol
Rajeev R. Samtani, Gregory Serrao
May 28, 2021 | Hurst's the Heart Updates
The Pooled SCORED and SOLOIST-WHF Analysis
Helen Hashemi, Jeffrey I. Mechanick
May 28, 2021 | Hurst's the Heart Updates
Angiotensin Receptor Neprilysin Inhibition Following Acute Myocardial Infarction: Primary Results of the PARADISE-MI Trial
Gennaro Giustino, Matthew Tomey
May 28, 2021 | Hurst's the Heart Updates
LAAOS III: Left Atrial Appendage Occlusion to Prevent Stroke in Patients with Atrial Fibrillation undergoing other Cardiac Surgery
Waqas A. Malick, Jacob Koruth
December 11, 2020 | Hurst's the Heart Updates
A Novel SGLT-1/2 Inhibitor Reduces Cardiovascular Events: Insights from the Scored and Soloist-WHF Trials
Michael B. Hadley, Jeffrey I. Mechanick
December 11, 2020 | Hurst's the Heart Updates
Acute Stroke or Transient Ischemic Attack Treated With Ticagrelor and Aspirin for Prevention of Stroke and Death - The Thales Trial
Gennaro Giustino, George Dangas
December 11, 2020 | Hurst's the Heart Updates
Tips-3 Review
Chris Pumill, Tara Naib
December 11, 2020 | Hurst's the Heart Updates
Clopidogrel verses ticagrelor in elective percutaneous coronary intervention – a closer look into the Alpheus trial
Rajeev R. Samtani, Gregory Serrao
December 11, 2020 | Hurst's the Heart Updates
A New Lipid Lowering Drug on the Horizon? An analysis of Evinacumab in Refractory Hypercholesterolemia
Benjamin Bier, Gina LaRocca
December 11, 2020 | Hurst's the Heart Updates
Galactic-HF: Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction
Steven A. Alexander, Anuradha Lala
December 11, 2020 | Hurst's the Heart Updates
Harp-Minoca review
Helen Hashemi, Javier Sanz
December 11, 2020 | Hurst's the Heart Updates
Critical analysis of the mSToPS trial: 3-year clinical outcomes of active screening for atrial fibrillation (AF) using ECG patch
Fahd Yunus, Mohamed Al-Kazaz
December 11, 2020 | Hurst's the Heart Updates
Review of One-Month DAPT Trial
Chi Zhang, Matthew Tomey
December 11, 2020 | Hurst's the Heart Updates
Critical Analysis of Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis (RHAPSODY)
Michael Healy, Martin Goldman
December 11, 2020 | Hurst's the Heart Updates
Monitoring for Atrial Fibrillation After Cardiac Surgery: Search-AF
Joshua Lampert, Jacob Koruth
December 11, 2020 | Hurst's the Heart Updates
The River Trial: Insight into the Use of Direct Oral Anticoagulation in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve
Waqas A. Malick, Daniella Kadian-Dodov
September 30, 2020 | Hurst's the Heart Updates
BPLTTC Study
Michael B. Hadley, Jeffrey I. Mechanick
September 30, 2020 | Hurst's the Heart Updates
EAST-AFNET4: Early Rhythm-Control Therapy in Patients with Atrial Fibrillation
Waqas A. Malick, Jacob Koruth
September 30, 2020 | Hurst's the Heart Updates
ELDERCARE-AF Review
Chris Pumill, Tara Naib
September 30, 2020 | Hurst's the Heart Updates
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
Benjamin Bier, Anuradha Lala
September 30, 2020 | Hurst's the Heart Updates
Critical Analysis of Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomized, double-blind, placebo-controlled, phase 3 trial
Michael Healy, Martin Goldman